Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Baird Downgrades PRA Health Sciences to Neutral, Announces $165 Price Target

Baird analyst Eric Coldwell downgrades PRA Health Sciences (NASDAQ:PRAH) from Outperform to Neutral and announces $165 price target.

Baird analyst Eric Coldwell downgrades PRA Health Sciences (NASDAQ:PRAH) from Outperform to Neutral and announces $165 price target.

Total
0
Shares
Related Posts